Monaghan offers leading aerosol drug delivery devices and respiratory management products including AeroEclipse® II BAN, AeroChamber Plus® aVHC and the Aerobika® OPEP device exclusively in the United States. Monaghan’s strength lies in product development around core capabilities in mechanical design complimented by collaboration with a state-of-the-art aerosol research laboratory. Monaghan focuses on developing cost-efficient, outcome-based solutions for its customers. https://www.monaghanmed.com